Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole vs Double-dose Lansoprazole in Overweight/Obese Reflux Esophagitis
NCT02759393Phase 4Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Oct 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dexlansoprazole in reflux esophagitis, sponsored by National Cheng Kung University Hospital. Status: unknown.
02
Drugs
dexlansoprazole
03
Conditions
reflux esophagitis
Beyond the preview
Go deeper on NCT02759393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02759393.